The Effect of High-Dose Vitamin D <sub>3</sub> on Soluble P-Selectin and hs-CRP Level in Patients With Venous Thromboembolism

Kheirollah Gholami, Azita H. Talasaz, Taher Entezari‐Maleki, Mojtaba Salarifar, Molouk Hadjibabaie, Mohammad Reza Javadi, Samaneh Dousti, Hadi Hamishehkar, Saleh Maleki

Clinical and Applied Thrombosis/Hemostasis · 2015 · 17 citations · 24 references

Concepts

Abstract

High plasma level of P-selectin is associated with the development of venous thromboembolism (VTE). Furthermore, supplementation of vitamin D could decrease thrombotic events. Hence, this study was designed to examine whether the administration of vitamin D can influence the plasma level of P-selectin in patients with VTE. In the randomized controlled trial, 60 patients with confirmed acute deep vein thrombosis and/or pulmonary embolism (PE) were randomized into the intervention (n = 20) and control (n = 40) groups. The intervention arm was given an intramuscular single dose of 300 000 IU vitamin D3 Plasma level of 25-hydroxy vitamin D, P-selectin, and high-sensitive C-reactive protein (hs-CRP) was measured at baseline and 4 weeks after. The plasma level of P-selectin (95% confidence interval = -5.99 to -1.63, P = .022) and hs-CRP (P = .024) significantly declined in vitamin D-treated group, while only hs-CRP was significantly decreased in the control group (P = .011). However, the magnitude of these reductions was not statistically significant. This study could not support the potential benefit of the high-dose vitamin D on plasma level of P-selectin and hs-CRP in patients with VTE.

References

24